Perrigo Company plc Payments for Derivative Instrument, Investing Activities
Perrigo Company plc (PRGO) reported Payments for Derivative Instrument, Investing Activities of $0 for the 9-month period ending 2025-09-27, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForDerivativeInstrumentInvestingActivities · last filed 2025-11-05
- Perrigo Company plc payments for derivative instrument, investing activities for the quarter ending 2025-09-27 was $0.00.
- Perrigo Company plc payments for derivative instrument, investing activities for the quarter ending 2024-09-28 was $0.00.
- Perrigo Company plc payments for derivative instrument, investing activities for the quarter ending 2023-09-30 was $0.00.
- Perrigo Company plc payments for derivative instrument, investing activities for the quarter ending 2022-10-01 was $0.00.
- Perrigo Company plc payments for derivative instrument, investing activities for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Perrigo Company plc payments for derivative instrument, investing activities for fiscal 2018 was $7.50M.
- Perrigo Company plc payments for derivative instrument, investing activities for fiscal 2017 was $0.00.
- Perrigo Company plc payments for derivative instrument, investing activities for fiscal 2016 was $0.00.
| Period end | Payments for Derivative Instrument, Investing Activities 3 month | Payments for Derivative Instrument, Investing Activities 6 month | Payments for Derivative Instrument, Investing Activities 6 month as first filed | Payments for Derivative Instrument, Investing Activities 9 month | Payments for Derivative Instrument, Investing Activities 12 month |
|---|---|---|---|---|---|
| 2025-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |||
| 2025-06-28 | $0.00 10-Q · filed 2025-08-06 | ||||
| 2024-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $45.80M 10-Q · filed 2025-11-05 | |||
| 2024-06-29 | $45.80M 10-Q · filed 2025-08-06 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |||
| 2023-07-01 | $0.00 10-Q · filed 2024-08-02 | ||||
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $37.10M 10-Q · filed 2023-11-07 | |||
| 2022-07-02 | $37.10M 10-Q · filed 2023-08-08 | ||||
| 2021-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |||
| 2021-07-03 | $0.00 10-Q · filed 2022-08-09 | ||||
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $7.50M 10-K · filed 2020-02-27 | ||
| 2018-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $7.50M 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $7.50M 10-Q · filed 2019-08-08 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | $0.00 10-K · filed 2019-02-27 | |
| 2016-10-01 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-05-23 | $0.00 derived: sum of 2 quarters · filed 2017-05-23 | $0.00 10-Q/A · filed 2017-05-23 | ||
| 2016-07-02 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $0.00 10-Q/A · filed 2017-05-22 | |||
| 2016-04-02 | $0.00 10-Q/A · filed 2017-05-22 | ||||
| 2015-12-31 | $1.30M 10-K · filed 2018-03-01 | $0.00 10-KT · filed 2016-02-25 | |||
| 2015-09-26 | $1.30M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-05-23 | $6.70M derived: sum of 2 quarters · filed 2017-05-23 | $304.80M 10-Q/A · filed 2017-05-23 | ||
| 2015-06-27 | $5.40M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $303.50M 10-Q/A · filed 2017-05-22 | $329.90M 10-K · filed 2018-03-01 | ||
| 2015-03-28 | $298.10M 10-Q/A · filed 2017-05-22 | $324.50M 10-Q · filed 2015-04-29 | |||
| 2014-12-27 | $26.40M 10-Q · filed 2015-02-05 | ||||
| 2014-06-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $0.00 derived: sum of 2 quarters · filed 2017-05-22 | $0.00 10-K · filed 2017-05-22 | ||
| 2014-03-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $0.00 10-Q · filed 2015-04-29 | |||
| 2013-12-28 | $0.00 10-Q · filed 2015-02-05 | ||||
| 2013-06-29 | $0.00 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |